Sotac Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 10, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	1,435	1,337	-	-	-	-
Enterprise Value	1,747	1,578	-	-	-	-
Last Close Price	129.85	121.00	-	-	-	-
PE Ratio	32.18	31.23	-	-	-	-
PS Ratio	1.37	1.29	-	-	-	-
PB Ratio	2.82	2.71	-	-	-	-
P/TBV Ratio	3.17	3.09	-	-	-	-
EV/Sales Ratio	1.67	1.52	-	-	-	-
EV/EBITDA Ratio	20.05	17.90	-	-	-	-
EV/EBIT Ratio	31.66	27.59	-	-	-	-
Debt / Equity Ratio	0.55	0.50	1.12	1.12	6.67	2.85
Debt / EBITDA Ratio	3.21	2.82	2.90	0.93	11.78	7.22
Debt / FCF Ratio	-	-	-	2.60	-	-
Asset Turnover	0.98	1.16	1.42	2.09	1.50	-
Inventory Turnover	4.92	5.03	6.02	10.95	11.02	-
Quick Ratio	0.54	0.69	0.55	0.45	0.31	0.41
Current Ratio	1.12	1.39	1.03	0.94	0.76	0.71
Return on Equity (ROE)	8.46%	10.37%	17.38%	62.65%	-64.97%	-
Return on Assets (ROA)	3.21%	4.00%	6.10%	12.24%	-2.19%	-
Return on Capital (ROIC)	4.69%	6.17%	11.92%	25.41%	-3.76%	-
Return on Capital Employed (ROCE)	8.80%	9.30%	19.10%	89.60%	-	4.20%
Earnings Yield	3.11%	3.20%	-	-	-	-
FCF Yield	-4.24%	-25.36%	-	-	-	-
Payout Ratio	-	-	-	15.98%	-	-
Buyback Yield / Dilution	-	-36.35%	-	-	-132.16%	-
Total Shareholder Return	-	-36.35%	-	-	-132.16%	-

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.